Valuation: Terumo Corporation

Market Cap 3,229B 19.99B 17.49B 16.13B 14.9B 28.27B 1,907B 28.74B 193B 75.68B 939B 75.06B 73.43B P/E 2027 *
19.3x
P/E 2028 * 17.4x
Enterprise Value 3,305B 20.46B 17.9B 16.51B 15.25B 28.93B 1,951B 29.41B 197B 77.45B 961B 76.82B 75.15B EV / Sales 2027 *
2.67x
EV / Sales 2028 * 2.47x
Free-Float
97.07%
Yield 2027 *
1.63%
Yield 2028 * 1.82%
1 day-1.73%
1 week-1.15%
Current month-2.01%
1 month-4.16%
3 months+0.83%
6 months-3.42%
Current year-3.57%
1 week 2,187
Extreme 2187
2,350
1 month 2,146.5
Extreme 2146.5
2,364.5
Current year 1,900
Extreme 1900
2,463
1 year 1,900
Extreme 1900
2,818
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
-1.73%-1.15%-11.75%+1.32% 20.24B
-0.31%-1.48%-29.48%-11.97% 164B
+1.57%+0.74%-6.40%-3.21% 105B
+0.58%+1.81%+2.23%+57.63% 58.85B
+0.79%-2.40%+44.99%+53.08% 51.05B
+0.96%-2.21%-14.31%-40.95% 41.57B
+0.17%-4.56% - - 34.54B
+2.55%+3.66%-12.20%-42.56% 28.18B
-1.05%-1.12%+54.26%-6.28% 25.27B
+0.16%+1.39%-6.27%-3.05% 21.05B
Average +0.32%-0.89%+2.34%+0.45% 55.06B
Weighted average by Cap. +0.40%-0.73%-5.88%+1.35%

Financials

2027 *2028 *
Net sales 1,236B 7.66B 6.7B 6.18B 5.7B 10.82B 730B 11.01B 73.8B 28.98B 360B 28.74B 28.12B 1,315B 8.14B 7.12B 6.57B 6.07B 11.51B 777B 11.71B 78.49B 30.82B 383B 30.57B 29.91B
Net income 166B 1.02B 896M 827M 764M 1.45B 97.73B 1.47B 9.88B 3.88B 48.15B 3.85B 3.76B 185B 1.15B 1B 925M 854M 1.62B 109B 1.65B 11.05B 4.34B 53.87B 4.31B 4.21B
Net Debt 75.69B 469M 410M 378M 349M 663M 44.69B 674M 4.52B 1.77B 22.02B 1.76B 1.72B 14.29B 88.47M 77.39M 71.38M 65.93M 125M 8.44B 127M 853M 335M 4.16B 332M 325M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
10/07/26 ¥2,189.00 -1.73% 4,601,900
09/07/26 ¥2,227.50 -2.15% 3,400,200
08/07/26 ¥2,276.50 -2.04% 5,188,900
07/07/26 ¥2,324.00 +1.33% 4,707,100
06/07/26 ¥2,293.50 +1.57% 2,726,200
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,189.00JPY
Average target price
2,961.54JPY
Spread / Average Target
+35.29%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock